Access to patient-level trial data--a boon to drug developers
N Engl J Med
.
2013 Oct 24;369(17):1577-9.
doi: 10.1056/NEJMp1310771.
Epub 2013 Oct 21.
Authors
Hans-Georg Eichler
1
,
Frank Pétavy
,
Francesco Pignatti
,
Guido Rasi
Affiliation
1
From the European Medicines Agency, London.
PMID:
24144395
DOI:
10.1056/NEJMp1310771
No abstract available
MeSH terms
Access to Information*
Clinical Trials as Topic*
Confidentiality
Drug Discovery*
Drug Industry*
Europe
Information Dissemination